Alfamed Fipronil 268 mg 100 mg/ml Spot-on solution
Alfamed Fipronil 268 mg 100 mg/ml Spot-on solution
Authorised
- Fipronil
Product identification
Medicine name:
FIPRALONE 268 mg Spot-on solution for large dogs
Alfamed Fipronil 268 mg 100 mg/ml Spot-on solution
Alfamed Fipronil 268 mg 100 mg/ml Spot-on oplossing
Alfamed Fipronil 268 mg 100 mg/ml Solution pour spot-on
Alfamed Fipronil 268 mg 100 mg/ml Lösung zum Auftropfen
Active substance:
- Fipronil
Target species:
-
Dog
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Fipronil100.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Spot-on use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AX15
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
- White multi-layer plastic single-dose pipettes containing an extractible volume of 2.68 ml. The internal layers in contact with the product are made of polyacrylonitrile-methacrylate. The white external complex is composed of polypropylene/ cyclic olefine copolymer/ polypropylene. Boxes of 1, 2, 3, 4, 6, 8, 12, 24, 30, 60, 90 or 150 pipettes. The boxes contain pipettes either with or without an individual blister for each pipette.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic (abridged application) - art 13(1)
Marketing authorisation holder:
- Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfamed
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V421084
Date of authorisation status change:
Reference member state:
-
Hungary
Procedure number:
- HU/V/0138/001-006
Concerned member states:
-
Belgium
-
Romania
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: